Help us: Donate
Follow us on:
×

Genflow Biosciences

Organization Description

 

GENFLOW is dedicated to the development and commercialization of novel therapeutics targeting human aging. They are developing minicircle plasmid vectors to allow a safe transient episomal expression of extra copies of the gene SIRT6 gene without integration into the DNA, without risk of self-replication, without transfer of bacterial genetic material, without immunogenic or mutagenesis concerns.

Team

Eric Leire, M.D.

Genflow Biosciences - CEO

Want the latest longevity news? Subscribe to our Newsletter!